DOAJ Open Access 2025

Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction

Ye Huang Wang Li Yuke Zhou Jinping Bai Ning Li +2 lainnya

Abstrak

<i>p53</i> is a tumor suppressor gene and is regarded as one of the most crucial genes in protecting humans against cancer. The protein Mdm2 and its homolog MdmX serve as negative regulators of p53. In nearly half of cancer cells, there is an overexpression of Mdm2 and MdmX, which inhibit p53 activity. Furthermore, Mdm2’s E3 ubiquitin ligase activity promotes the ubiquitination and degradation of p53. Therefore, blocking the interaction between p53 and Mdm2/MdmX to prevent the degradation of wild-type p53 is an effective strategy for inhibiting tumor growth. This paper primarily discusses the regulatory relationship between p53, MdmX and Mdm2, and provides a review of the current status of p53-Mdm2/MdmX inhibitors. It aims to offer a theoretical foundation and research direction for the future discovery and design of targeted inhibitors against the p53-Mdm2/MdmX interaction.

Topik & Kata Kunci

Cytology

Penulis (7)

Ye Huang

Wang Li

Yuke Zhou

Jinping Bai

Ning Li

Zhengding Su

Xiyao Cheng

Format Sitasi

APA MLA BibTeX

Huang, Y., Li, W., Zhou, Y., Bai, J., Li, N., Su, Z. et al. (2025). Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction. https://doi.org/10.3390/cells14080583

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.3390/cells14080583

Informasi Jurnal

Tahun Terbit: 2025
Sumber Database: DOAJ
DOI: 10.3390/cells14080583
Akses: Open Access ✓